Suzhou Ribo Life Science Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
228
- Latest Deal Type
-
Series E1
- Latest Deal Amount
-
$40M
- Investors
-
30
Suzhou Ribo Life Science General Information
Description
Developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.
Contact Information
Website
www.ribolia.comCorporate Office
- No.168 Yuanfeng Road
- Yushan Town
- Kunshan, Jiangsu 215300
- China
Corporate Office
- No.168 Yuanfeng Road
- Yushan Town
- Kunshan, Jiangsu 215300
- China
Suzhou Ribo Life Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series E1) | 29-Jul-2022 | $40M | Completed | Generating Revenue | ||
| 8. IPO | 31-May-2021 | Cancelled | Generating Revenue | |||
| 7. Later Stage VC (Series C3) | 11-Sep-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C2) | 03-Apr-2020 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 18-Mar-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C1) | 05-Dec-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 17-Mar-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 28-Sep-2015 | $19.6M | $26.6M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 31-Dec-2013 | $7M | $7M | Completed | Generating Revenue |
Suzhou Ribo Life Science Comparisons
Industry
Financing
Details
Suzhou Ribo Life Science Competitors (45)
One of Suzhou Ribo Life Science’s 45 competitors is WaVe Life Sciences, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| WaVe Life Sciences | Formerly VC-backed | Cambridge, MA | ||||
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
| Cyclenium Pharma | Corporate Backed or Acquired | Montreal, Canada | ||||
| Apeptico | Venture Capital-Backed | Vienna, Austria |
Suzhou Ribo Life Science Patents
Suzhou Ribo Life Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023253037-A1 | Conjugate and composition as well as preparation method therefor and use thereof | Pending | 14-Apr-2022 | ||
| AU-2023252276-A1 | Aptamer, conjugate, composition, method for preparing same, and use thereof | Pending | 14-Apr-2022 | ||
| AU-2022422864-A1 | Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof | Pending | 21-Dec-2021 | ||
| CA-3242059-A1 | Nucleic acid, composition and conjugate containing nucleic acid, preparation method thereof and use thereof | Pending | 21-Dec-2021 | ||
| JP-2024546667-A | Nucleic acids, compositions and complexes containing the same, and methods of preparation and use | Pending | 21-Dec-2021 | C12N15/113 |
Suzhou Ribo Life Science Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Suzhou Ribo Life Science Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kunshan Guoke Venture Capital | Government | Minority | ||
| Qirong Venture Capital | Venture Capital | Minority | ||
| Shangqi Capital | Corporate Venture Capital | Minority | ||
| China Reform Holdings Corporation | Corporation | Minority | ||
| Everest VC | Venture Capital | Minority |
Suzhou Ribo Life Science Investments (1)
Suzhou Ribo Life Science’s most recent deal was a Joint Venture with Kunshan RiboQuark Pharmaceutical Technology. The deal was made on 01-Sep-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kunshan RiboQuark Pharmaceutical Technology | 01-Sep-2012 | Joint Venture | Pharmaceuticals |
Suzhou Ribo Life Science FAQs
-
When was Suzhou Ribo Life Science founded?
Suzhou Ribo Life Science was founded in 2007.
-
Where is Suzhou Ribo Life Science headquartered?
Suzhou Ribo Life Science is headquartered in Kunshan, China.
-
What is the size of Suzhou Ribo Life Science?
Suzhou Ribo Life Science has 228 total employees.
-
What industry is Suzhou Ribo Life Science in?
Suzhou Ribo Life Science’s primary industry is Biotechnology.
-
Is Suzhou Ribo Life Science a private or public company?
Suzhou Ribo Life Science is a Private company.
-
What is Suzhou Ribo Life Science’s current revenue?
The current revenue for Suzhou Ribo Life Science is .
-
How much funding has Suzhou Ribo Life Science raised over time?
Suzhou Ribo Life Science has raised $236M.
-
Who are Suzhou Ribo Life Science’s investors?
Kunshan Guoke Venture Capital, Qirong Venture Capital, Shangqi Capital, China Reform Holdings Corporation, and Everest VC are 5 of 30 investors who have invested in Suzhou Ribo Life Science.
-
Who are Suzhou Ribo Life Science’s competitors?
WaVe Life Sciences, NexImmune, CRISPR Therapeutics, Cyclenium Pharma, and Apeptico are some of the 45 competitors of Suzhou Ribo Life Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
